Oct. 28, 2021
InBios Receives FDA EUA for COVID-19 Neutralizing Antibody ELISA
By info@inbios.com|2023-10-25T19:49:54+00:00November 1st, 2021|InBios In the News|
InBios Receives FDA EUA for COVID-19 Neutralizing Antibody ELISA
By info@inbios.com|2023-10-25T19:52:25+00:00October 4th, 2021|InBios In the News|
InBios Receives FDA EUA for COVID-19 IgG Antibody Rapid Test
By info@inbios.com|2023-10-25T19:52:42+00:00October 4th, 2021|InBios In the News|
New Studies Suggest InBios COVID-19 POC Antigen Test Will Detect Delta Variant
By info@inbios.com|2023-10-25T19:53:12+00:00October 4th, 2021|InBios In the News|
Curebase, InBios Announce Results of Virtual Clinical Trial
By info@inbios.com|2023-10-25T19:53:30+00:00May 12th, 2021|InBios In the News|
InBios Receives FDA EUA for COVID-19 POC Antigen Detection Test
By info@inbios.com|2023-10-25T19:53:47+00:00November 9th, 2020|InBios In the News|
InBios Awarded Contract Through US Army for SCoV-2 Infection Clinical Trials
By info@inbios.com|2023-10-25T19:54:06+00:00November 2nd, 2020|InBios In the News|
InBios Awarded $12.7M to Boost Production of Two COVID-19 Diagnostics
By info@inbios.com|2023-10-25T19:54:31+00:00November 2nd, 2020|InBios In the News|
DoD Awards $12.67 Million Contract Action to InBios International Inc.
By info@inbios.com|2023-10-25T19:55:34+00:00July 6th, 2020|InBios In the News|
InBios Gets FDA EUA for Second Coronavirus Antibody Test
By info@inbios.com|2023-10-25T19:55:53+00:00July 1st, 2020|InBios In the News|
InBios Receives FDA EUA for Second COVID-19 Antibody Test